Онкология
2366 статей · 70 журналов
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (100)
- European Journal of Surgical Oncology · Elsevier (95)
- Cancer Treatment and Research Communications · Elsevier (93)
- The Lancet Oncology · Elsevier (93)
- Brachytherapy · Elsevier (91)
- Cancer Epidemiology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- International Journal of Gynecological Cancer · Elsevier (88)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (68)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Response to the letter RE: Assessing the magnitude of surveillance bias in prostate cancer, melanoma and lung cancer
- Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study
- Letter re: “diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis"
- Editorial board
- Outcomes of CD20-targeting CAR T-cell therapy in patients with advanced melanoma: MB-CART20.1 Melanoma phase I trial
- Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial
- A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials
- Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer
- From staging to changing strategy: [18F]FDG PET/MRI’s impact on treatment planning in early breast cancer
- Risk stratification and potential overtreatment in adjuvant CDK4/6 inhibitor trials: do all patients with Stage II disease and favorable biology derive benefit?
- PELICAN-IPC 2015–016/Oncodistinct-003: A randomized non-comparative phase II study of pembrolizumab in combination with neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer
- Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
- Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
- Diagnostic challenges in WHO classification of thymic epithelial tumors: The clinical value of an international expert pathology panel
- Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab
- Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study
- Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort
- Mapping the overlap of predictive biomarkers in an advanced Austrian multicenter gastroesophageal adenocarcinoma real-world cohort - results from the AGMT GASTRIC-5 registry
- Factors associated with chemotherapy free interval (CFI) after induction chemotherapy in metastatic colorectal cancer (mCRC) based on a meta-analysis on ARCAD CRC database: The CFI-SCORE project
- Preventing progression to reduce costs: A cost-effectiveness analysis of enfortumab vedotin+pembrolizumab in MIBC
- "HPV16 circulating tumour DNA for prognostic stratification and post-treatment surveillance in HPV-positive oropharyngeal cancer: A multinational study"
- Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
- Title page
- Disclaimer
- Radiation-induced brain necrosis among patients with nasopharyngeal cancer treated with proton vs photon radiotherapy
- Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)
- Osteosarcoma as a second or later malignancy: Presentation, treatment, and survival of 198 patients from the Cooperative Osteosarcoma Study Group
- Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies
- Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis
- A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study